Mr. Speaker, that was an awfully vague answer about a specific question. Let me ask about a very specific concern.
We know that lobbyists for the Pharmaceutical Manufacturers Association of Canada, which is fighting to scrap a national drug plan, are coming from former employees of the Patented Medicine Prices Review Board.
Given the revolving door between industry and government and real concerns about conflict of interest, we want to know if Canadians can be assured that the federal government and not the brand name industry is setting drug prices.